These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16775432)

  • 1. CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients.
    Zhang Q; Chen X; Zhou J; Zhang L; Zhao Q; Chen G; Xu J; Qian F; Chen Z
    Cancer Biol Ther; 2006 Jul; 5(7):808-14. PubMed ID: 16775432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor microvascular density detected by anti-CD105 and anti-CD34 in hepatocellular carcinoma patients and its predictive value of tumor recurrence after liver transplantation].
    Wang Y; Zhang XH; Guo P; Yan LN; He D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):818-21. PubMed ID: 21302449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.
    Yang LY; Lu WQ; Huang GW; Wang W
    BMC Cancer; 2006 May; 6():110. PubMed ID: 16650286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD147 as a significantly unfavorable prognostic factor in hepatocellular carcinoma.
    Zhang Q; Zhou J; Ku XM; Chen XG; Zhang L; Xu J; Chen GS; Li Q; Qian F; Tian R; Wen N; Chen ZN
    Eur J Cancer Prev; 2007 Jun; 16(3):196-202. PubMed ID: 17415090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study.
    Poon RT; Ng IO; Lau C; Yu WC; Yang ZF; Fan ST; Wong J
    J Clin Oncol; 2002 Apr; 20(7):1775-85. PubMed ID: 11919234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.
    Zheng HC; Takahashi H; Murai Y; Cui ZG; Nomoto K; Miwa S; Tsuneyama K; Takano Y
    Br J Cancer; 2006 Nov; 95(10):1371-8. PubMed ID: 17088917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation.
    Salizzoni M; Romagnoli R; Lupo F; David E; Mirabella S; Cerutti E; Ottobrelli A
    Transplantation; 2003 Sep; 76(5):844-8. PubMed ID: 14501865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The angiogenic and prognostic implications of VEGF, Ang-1, Ang-2, and MMP-9 for hepatocellular carcinoma with background of hepatitis B virus.
    Chen ZB; Shen SQ; Ding YM; Wang WX; Tao JP; Liang LJ; Hu WJ
    Med Oncol; 2009; 26(3):365-71. PubMed ID: 19082771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix Metalloproteinase 1 as a Novel Biomarker for Monitoring Hepatocellular Carcinoma in Liver Transplant Patients.
    Sánchez-Lorencio MI; Saenz L; Ramirez P; Villalba-López F; de la Orden V; Mediero-Valeros B; Revilla Nuin B; Gonzalez MR; Cascales-Campos PA; Ferreras-Martínez D; Noguera-Velasco JA; Díaz-Rubio E; Parrilla P
    Transplant Proc; 2018 Mar; 50(2):623-627. PubMed ID: 29579870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
    Zou WL; Zang YJ; Chen XG; Shen ZY
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.
    Nart D; Yaman B; Yilmaz F; Zeytunlu M; Karasu Z; Kiliç M
    Liver Transpl; 2010 May; 16(5):621-30. PubMed ID: 20440771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation.
    Campillo A; Solanas E; Morandeira MJ; Castiella T; Lorente S; Garcia-Gil FA; Piazuelo E; de Martino A; Serrano MT
    Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):871-9. PubMed ID: 24922356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of hepatocellular carcinoma recurrence after liver transplantation: accuracy of the alpha-fetoprotein model in a single-center experience.
    Varona MA; Soriano A; Aguirre-Jaime A; Garrido S; Oton E; Diaz D; Portero J; Bravo P; Barrera MA; Perera A
    Transplant Proc; 2015; 47(1):84-9. PubMed ID: 25645778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Fibrogenic Markers in Tumor and Tumor-Surrounding Tissue at Time of Transplantation Correlates with Recurrence of Hepatocellular Carcinoma in Patients Undergoing Liver Transplantation.
    Kocabayoglu P; Piras-Straub K; Gerken G; Paul A; Herzer K
    Ann Transplant; 2017 Jul; 22():446-454. PubMed ID: 28729525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expressions of inducible nitric oxide synthase and matrix metalloproteinase-9 and their effects on angiogenesis and progression of hepatocellular carcinoma.
    Sun MH; Han XC; Jia MK; Jiang WD; Wang M; Zhang H; Han G; Jiang Y
    World J Gastroenterol; 2005 Oct; 11(38):5931-7. PubMed ID: 16273602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma.
    Murakami K; Kasajima A; Kawagishi N; Sekiguchi S; Fujishima F; Watanabe M; Sato Y; Ohuchi N; Sasano H
    Hum Pathol; 2014 Mar; 45(3):589-97. PubMed ID: 24444468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and clinical impact of vascular endothelial growth factor and matrix metalloproteinase-2 in hepatocellular carcinoma].
    Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):285-8. PubMed ID: 16875630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Full-length soluble CD147 promotes MMP-2 expression and is a potential serological marker in detection of hepatocellular carcinoma.
    Wu J; Hao ZW; Zhao YX; Yang XM; Tang H; Zhang X; Song F; Sun XX; Wang B; Nan G; Chen ZN; Bian H
    J Transl Med; 2014 Jul; 12():190. PubMed ID: 24996644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.